Industry reports
Editor highlights

Quintiles Transnational Corp Strategy and SWOT Report

We are sorry but this premium report expired!

This market research, not available anymore on the publisher's website, was withdrawn from our database.

To get an alternative report, you can either :

  • Have a look at the list of documents hereafter
  • Launch a new search below

Search ReportLinker

The Largest Collection of Market Research Reports

» 1.2 Million Industry Reports
» 450,000 Company Profiles
» 850,000 Market Briefings
» 40,000 Country Guides

From +200,000 authoritative sources

DOWNLOAD THESE REPORTS NOW!

Verenium Corporation (Symbol:VRNM) SWOT Analysis, Strategy, Revenues and Profits

Verenium Corporation (Symbol:VRNM) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • by Global Data
  • April 2014
  • 25 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. Verenium Corporation SWOT Analysis report provides you a strategic ...

Industries: Biopharmaceutical | Countries: United States

Calypte Biomedical Corporation (Symbol:CBMC) SWOT Analysis, Strategy, Revenues and Profits

Calypte Biomedical Corporation (Symbol:CBMC) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • by Global Data
  • April 2014
  • 25 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. Calypte Biomedical Corporation SWOT Analysis report provides you a ...

Industries: Biopharmaceutical | Countries: United States

BioMedical Enterprises, Inc. SWOT Analysis, Strategy, Revenues and Profits

BioMedical Enterprises, Inc. SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • by Global Data
  • April 2014
  • 15 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. SWOT Analysis report provides you a strategic analysis and detailed ...

Industries: Biopharmaceutical | Countries: United States

QuantRx Biomedical Corporation (Symbol:QTXB) SWOT Analysis, Strategy, Revenues and Profits

QuantRx Biomedical Corporation (Symbol:QTXB) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • by Global Data
  • April 2014
  • 25 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. QuantRx Biomedical Corporation SWOT Analysis report provides you a ...

Industries: Biopharmaceutical | Countries: United States

Physician Views - Are physicians getting the biosimilar education they need?

Physician Views - Are physicians getting the biosimilar education they need?

  • $ 731
  • Industry report
  • by Firstword Pharma
  • April 2014

Biosimilars remain one of the pharmaceutical industry's hot topics. Branded biologics account for 7 of the 10 best selling drugs globally and significant legislative momentum was provided in 2013 when the European Medicines Agency (EMA) approved its first biosimilar antibody products (versions of the ...

Industries: Biopharmaceutical | Countries: United States

Accentia Biopharmaceuticals, Inc. (ABPI) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Accentia Biopharmaceuticals, Inc. (ABPI) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • by Global Data
  • March 2014
  • 39 pages

Summary Accentia Biopharmaceuticals, Inc. (Accentia) is a biotechnology company. It identifies, develops and commercializes patent-protected disruptive healthcare technologies for the treatment of chronic and life threatening diseases including the respiratory, autoimmune and cancer indications. The ...

Industries: Biopharmaceutical | Countries: United States

Competitor Analysis: Cancer Vaccines

Competitor Analysis: Cancer Vaccines

  • $ 1 056
  • Industry report
  • by La Merie Publishing
  • March 2014
  • 179 pages

Cancer Vaccines The present Competitive Intelligence report about Cancer Vaccines provides a competitor evaluation in the field of novel prophylactic and therapeutic vaccines to fight cancer as of March 2014. Purchase of the downloadable pdf report includes a 6-month online access to the data of ...

Industries: Biopharmaceutical | Countries: United States

Alcohol and Starch/Sugar Enzyme Market by Type (Carbohydrase, Protease, and Lipase), by Application (Industrial, Specialty) & Geography - Global Trends & Forecasts to 2018

Alcohol and Starch/Sugar Enzyme Market by Type (Carbohydrase, Protease, and Lipase), by Application (Industrial, Specialty) & Geography - Global Trends & Forecasts to 2018

  • $ 4 650
  • Industry report
  • by MarketsandMarkets
  • March 2014
  • 209 pages

Alcohol enzymes are extensively used in various industrial applications that incorporate the production of food and beverages, biofuels, cleaning agents, and others. Due to their versatile applications, alcohol enzymes are in great demand to suffice the tremendous requirement for industrial products ...

Industries: Biopharmaceutical | Countries: World, France, United States, South Africa, North America, Brazil, Mexico, Canada, Germany, Japan, India, China, Europe, Africa

Navidea Biopharmaceuticals, Inc. (NAVB) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Navidea Biopharmaceuticals, Inc. (NAVB) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • by Global Data
  • March 2014
  • 21 pages

Summary Navidea Biopharmaceuticals, Inc. (Navidea) is a biopharmaceutical company with the focus on the development and commercialization of radiopharmaceutical agent and precision diagnostics. The company's development product in the pipeline include Lymphoseek, a radiopharmaceutical agent for lymph ...

Industries: Biopharmaceutical | Countries: United States

EnWave Corporation (Symbol:ENW) SWOT Analysis, Strategy, Revenues and Profits

EnWave Corporation (Symbol:ENW) SWOT Analysis, Strategy, Revenues and Profits

  • $ 125
  • Company report
  • by Global Data
  • March 2014
  • 35 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. EnWave Corporation SWOT Analysis report provides you a strategic analysis ...

Industries: Biopharmaceutical | Countries: United States

24/7 Customer Service

You can call our customer service 24 hours a day / 7 days a week

  • +1 917 267 7886

ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.